PEN - Penumbra, Inc.
122.95 0.00 (0.00%)
After hours: 4:19PM EDT
| Previous Close | 124.75 |
| Open | 125.20 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 122.80 - 125.35 |
| 52 Week Range | 77.75 - 127.40 |
| Volume | 107,396 |
| Avg. Volume | 262,891 |
| Market Cap | 4.196B |
| Beta | -0.00 |
| PE Ratio (TTM) | 945.77 |
| EPS (TTM) | 0.13 |
| Earnings Date | May 8, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 125.33 |
- PR Newswire•5 days ago
Penumbra, Inc. Schedules First Quarter 2018 Earnings Release and Conference Call for May 8, 2018
ALAMEDA, Calif. , April 18, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2018 after market close ...
Markit•8 days agoSee what the IHS Markit Score report has to say about Penumbra Inc.
Short interest is moderate for PEN with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
- Simply Wall St.•last month
With A -68.56% Earnings Drop, Did Penumbra Inc (NYSE:PEN) Really Underperform?
Improvement in profitability and outperformance against the industry can be important characteristics in a stock for some investors. Below, I will assess Penumbra Inc’s (NYSE:PEN) track record on a highRead More...
Markit•last monthSee what the IHS Markit Score report has to say about Penumbra Inc.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding PEN is favorable, with net inflows of $4.15 billion.
- Simply Wall St.•last month
What Should We Expect From Penumbra Inc’s (NYSE:PEN) Earnings In The Year Ahead?
Looking at Penumbra Inc’s (NYSE:PEN) earnings update in December 2017, the consensus outlook from analysts appear fairly confident, as a 29.55% increase in profits is expected in the upcoming year,Read More...
Markit•2 months agoSee what the IHS Markit Score report has to say about Penumbra Inc.
Short interest is moderate for PEN with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ETFs that hold PEN had net inflows of $913 million over the last one-month.
- GlobeNewswire•2 months ago
Analysis: Positioning to Benefit within Penumbra, Qualys, OraSure Technologies, Air Lease, Aduro Biotech, and Progenics Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, March 01, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of PEN earnings conference call or presentation 27-Feb-18 10:00pm GMT
Q4 2017 Penumbra Inc Earnings Call
- Zacks•2 months ago
Penumbra (PEN) Posts Earnings in Q4, Revenues Top Estimates
Penumbra (PEN) sees strong growth across all geographical regions and product lines in Q4.
- Associated Press•2 months ago
Penumbra beats Street 4Q forecasts
The Alameda, California-based company said it had profit of 25 cents per share. Earnings, adjusted for non-recurring gains, were 10 cents per share. The results topped Wall Street expectations. The average ...
- PR Newswire•2 months ago
Penumbra, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results
ALAMEDA, Calif. , Feb. 27, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth quarter and full ...
- ACCESSWIRE•2 months ago
Penumbra, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 27, 2018 / Penumbra, Inc. (NYSE: PEN ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 5:00 PM Eastern Time. ...
- Zacks•2 months ago
Is a Surprise Coming for Penumbra (PEN) This Earnings Season?
Penumbra (PEN) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
- Simply Wall St.•2 months ago
Is Penumbra Inc (NYSE:PEN) An Industry Laggard Or Leader?
Penumbra Inc (NYSE:PEN), a US$3.35B mid-cap, is a healthcare company operating in an industry, which continues to be affected by the sustained economic uncertainty and structural trends, such as anRead More...
- Benzinga•2 months ago
Penumbra Has Challenged The 'Paradigm' Of Stroke Treatment; William Blair Initiates At Outperform
Penumbra Inc (NYSE: PEN ) shares trended higher Wednesday on the confidence of one new analyst. The Rating William Blair analyst Kaila Krum initiated coverage with an Outperform rating. The Thesis Penumbra ...
- Zacks•2 months ago
Key Factors to Influence Penumbra's (PEN) Earnings in Q4
Penumbra (PEN) expects to gain from solid performance by neuro and peripheral vascular arms in Q4. Strong growth across all geographies is likely to drive the top line.
- Simply Wall St.•2 months ago
Should You Buy Penumbra Inc (NYSE:PEN) At $93.6?
Penumbra Inc (NYSE:PEN), a medical equipment company based in United States, saw a decent share price growth in the teens level on the NYSE over the last few months. WithRead More...
Markit•2 months agoSee what the IHS Markit Score report has to say about Penumbra Inc.
Short interest is moderate for PEN with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
Markit•2 months agoSee what the IHS Markit Score report has to say about Penumbra Inc.
Short interest is moderate for PEN with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ETFs that hold PEN had net inflows of $940 million over the last one-month.
- PR Newswire•3 months ago
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call for February 27, 2018 at 5:00 PM Eastern Time
ALAMEDA, Calif. , Jan. 30, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and year ended December ...
- Simply Wall St.•3 months ago
Should You Be Concerned About Penumbra Inc’s (NYSE:PEN) Investors?
I am going to take a deep dive into Penumbra Inc’s (NYSE:PEN) most recent ownership structure, not a frequent subject of discussion among individual investors. A company’s ownership structure isRead More...
- Business Wire•3 months ago
Independent Study Reaffirms Penumbra Aspiration as Frontline Thrombectomy Approach for Acute Ischemic Stroke
Penumbra, Inc. , a global healthcare company focused on innovative therapies, today announced the presentation of the results of the COMPASS Trial, an independent, prospective, multi-center randomized trial that showed the use of Penumbra’s aspiration system was non-inferior to stent retrievers for patients with acute ischemic stroke.
- Business Wire•3 months ago
Aspiration First Approach with Penumbra System Demonstrates Favorable Outcomes for Acute Ischemic Stroke
Penumbra, Inc. , a global healthcare company focused on innovative therapies, today announced results of the company-sponsored PROMISE Study, demonstrating real-world safety and efficacy of the Penumbra System with ACE™68 and ACE™64 Reperfusion Catheters as frontline treatment in patients with acute ischemic stroke using the ADAPT approach.
- Business Wire•3 months ago
Penumbra Announces Key Events at International Stroke Conference 2018 Meeting
Penumbra, Inc. , a global healthcare company focused on innovative therapies, today announced key events at the upcoming International Stroke Conference 2018 meeting to be held January 24-26 at the Los Angeles Convention Center.
- Simply Wall St.•3 months ago
Is Penumbra Inc (NYSE:PEN) As Financially Strong As Its Balance Sheet Indicates?
Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as Penumbra Inc (NYSE:PEN), with a market capitalization of $2.94B, rarely draw their attention from the investing community.Read More...
